Positron Emission Tomography with ¹¹C-D-deprenyl in Patients with Rheumatoid Arthritis

References

• Rydgren Wollmer L., Hultqvist P. R., Gustafsson T. 111Indium-labelled leukocytes for measurement of inflammatory activity in arthritis. Scand J. Rheumatol 1991; 20: 319–25
   PubMedGoogle Scholar
• Herve-Somma C., Sebag G H, Prieur A-M, Bonnerot V, Lallemand DP. Juvenile rheumatoid arthritis of the knee: MR evaluation with Gd-DOTA. Radiology 1992; 182: 93–8
   PubMed Web of Science ®Google Scholar
• Ahlström H, Feltelius N, Nyman R, Hallgren R. Magnetic resonance imaging of sacroiliac joint inflammation. Arthritis Rheum 1990; 33: 1763–69
   PubMed Web of Science ®Google Scholar
• Ostergaard M, Gideon P, Henriksen O, Lorenzen I. Synovial volume - a marker of disease severity in rheumatoid arthritis? Quantification by MRI. Scand J. Rheumatol 1994; 23: 197–202
   PubMed Web of Science ®Google Scholar
• Conference on outcome measures in rheumatoid arthritis clinical trials. Maastricht, the Netherlands April 29-May 3 1992. J Rheumatol 1993; 20: 526–91
   Google Scholar
• Van Leeuwen M A, Heijde D MFM, Van Rijswijk H, Houtman P M, Van Riel P LC M, van De Putte L BA, et al. Interrelationship of outcome measures and process variables in early rheumatiod arthritis. A comparison of radiological damage, physical disability joint counts, and acute phase reactants. J Rheumatol 1994; 21: 425–9
   PubMed Web of Science ®Google Scholar
• van der Lubbe P AHM, Arndt J W, Calame W, Ferreira T C, Pauwels E KJ, Breedveld FC. Measurement of synovial inflammation in rheumatoid arthritis with technetium-99m-labelled human polyclonal immunoglobulin G. Eur J Nucl Med 1991; 18: 119–23
   PubMedGoogle Scholar
• Oyen W JG, Boerman O C, van der Laken C J, Claessens R AMJ, van der Meer J WM, Corstens F HM. The uptake mechanisms of inflammation-and infection-localizing agents. Eur J Nucl Med 1996; 23: 459–65
   PubMedGoogle Scholar
• Jones H A, Clark R J, Rhodes C G, Schofield J B, Krausz T, Haslett C. Positron emission tomography of 18FDG uptake in localized pulmonary inflammation. Acta Radiol Suppl 1991; 376: 148
   PubMedGoogle Scholar
• Stoppe G, Wildhagen K, Seidel JW, et al. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 1990; 40: 304–8
   PubMed Web of Science ®Google Scholar
• Polisson R P, Schoenberg O I, Fischman A, Rubin R, Simon L S, Rosenthal D, Palmer WE. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Reum 1995; 38: 819–25
   PubMedGoogle Scholar
• Palmer W E, Rosenthal D I, Schoenberg O I, Fischman A J, Simon L S, Rubin RH, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology 1995; 196: 647–55
   PubMed Web of Science ®Google Scholar
• Kops E R, Herzog H, Schmid A, Holte S, Feinendegen LE. Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr 1990; 14: 437–45
   PubMed Web of Science ®Google Scholar
• Fowler J S, Mac Gregor R R, Wolf AP, et al. Mapping of brain monoamine oxidase A and B with 11C-labelled suicide inactiv-ators and PET. Science 1987; 235: 481–5
   PubMed Web of Science ®Google Scholar
• MacGregor R R, Fowler J S, Wolf A P, Halldin C, Långström B. Synthesis of suicide inhibitors of monoamine oxidase: carbon-11 labeled clorgyline, L- and D-deprenyl. J Label Compd Radiopharm 1988; 25: 1–12
   Google Scholar
• Patlak C S, Blasberg R G, Fenstermacher JD. Graphic evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1–7
   PubMed Web of Science ®Google Scholar
• Luthra S K, Turton D R, Vaja V, Dowsett K, Brady F. An automated system based on solid phase extraction and HPLC for the routine determination in plasma of unchanged (11)C-L-deprenyl; (11C)diprenorphine: (11C)raclopride; and (11C)Schering 23390. Abstract IXth international symposium on radiopharmaceutical chemistry. John Wiley & Sons, Ltd, Paris 1992; 518–20
   Google Scholar
• De Duve C, De Barsy T, Poole B, Trouet A, Tulkens P, Van Hoof F. Lysosomotropic agents. Biochem Pharmacol 1974; 23: 2495–531
   PubMed Web of Science ®Google Scholar
• Raghoebar M, Peeters P, van den Berg W B, Van Ginneken C. Mechanisms of cell association of chloroquine to leucocytes. J Pharmacol Exp Ther 1986; 238: 302–6
   PubMedGoogle Scholar
• Cramb G. Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems. Biochem Pharmacol 1986; 35: 1365–72
   PubMed Web of Science ®Google Scholar
• Bergström M, Muhr C, Jossan S, Lilja A, Nyberg G, Längström B. Differentiation of pituitary adenoma and meningioma: visualization with positron emission tomography and (11C)-L-deprenyl. Neurosurgery 1992; 30: 855–61
   PubMed Web of Science ®Google Scholar
• Muhr C, Bergström M. Positron emission tomography applied in the study of pituitary adenomas. J Endocrinol Invest 1991; 14: 509–28
   PubMed Web of Science ®Google Scholar